← Eichor
Condition: Blood Platelet Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Blood Platelet Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
Phase N/A · 1 location(s) · Nicoletta C Machin · NCT07083583Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed
Phase 3 · 36 location(s) · Sanofi · NCT07007962IASO-782 in Autoimmune Hematological Diseases
Phase 1 · 2 location(s) · Shanghai IASO Biotechnology Co., Ltd · NCT06534021Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Phase 1 · 4 location(s) · Cellenkos, Inc. · NCT05423691AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positiv
Phase 3 · 42 location(s) · University Hospital, Brest · NCT05198960Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06281327An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia
Phase 3 · 9 location(s) · Grand Shuyang Life Sciences (Chengdu) Co., Ltd. · NCT07233213A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · 21 location(s) · Janssen Research & Development, LLC · NCT06449651Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06577909Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women
Phase 2/Phase 3 · 1 location(s) · Genesis Athens Clinic · NCT03951194Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06102694Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT05931718Efficacy of INM004 in Children With STEC-HUS
Phase 3 · 52 location(s) · Inmunova S.A. · NCT06389474The Severe Von Willebrand Disease (sVWD) Patient Registry
Phase N/A · 1 location(s) · VWD Connect Foundation · NCT05437536The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thromboc
Phase 2 · 3 location(s) · Peking University People's Hospital · NCT07065968A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Mye
Phase 1 · 29 location(s) · Incyte Corporation · NCT05936359A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Phase 1/Phase 2 · 3 location(s) · Keymed Biosciences Co.Ltd · NCT07175493Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study
Phase N/A · 1 location(s) · Turkish Hematology Association · NCT05950750Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Phase 2 · 1 location(s) · University of Manitoba · NCT06599762Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)
Phase N/A · 1 location(s) · University Hospital, Rouen · NCT06945861Transmission Electron Microscopy Images for Platelet Ultrastructural Criteria Before and After the Onset of an Antiplate
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT05004233Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease
NA · 17 location(s) · University Hospital, Lille · NCT06651255Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07362238External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
Phase N/A · 16 location(s) · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT07418099A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · 25 location(s) · Hemab ApS · NCT06754852A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · 94 location(s) · argenx · NCT06544499A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Phase 3 · 28 location(s) · Kedrion S.p.A. · NCT07059000Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Diso
Phase 2 · 40 location(s) · Incyte Corporation · NCT07104565Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT03255928
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.